Deliver Your News to the World

(OTC: TZMT) Completes Prototype of Core Bluetooth® Solution


(CybeRelease, June 1, 2006) - Lake Harmony, PA - Telzuit Medical Technologies, Inc. (OTCBB: TZMT) announced today that it has successfully tested a prototype of its wireless heart monitor utilizing Bluetooth® technology delivered by Cambridge Silicon Radio’s (CSR) BlueCore3. The integration of this Bluetooth component signifies the final step in the development of Telzuit’s flagship 12-lead wireless heart monitor, readying the product for its initial production run and positioning it for formal launch in 2006. The completion of this prototype also clears the way for final development and implementation of the Company’s other leading mobile medical devices, including: an FDA-approved 12-lead wireless cardiac event monitor; a home sleep apnea test; and a long-term care patient solution incorporating the Company’s core wireless technology.

To read the complete release, go to

CybeRelease Gainers are Epoch Holding Corporation (Nasdaq: EPHC), Senomyx, Inc. (Nasdaq: SNMX), Gallery of History, Inc. (Nasdaq: HIST), Sangamo BioSciences, Inc. (Nasdaq: SGMO), CIENA Corporation (Nasdaq: CIEN), Simclar, Inc. (Nasdaq: SIMC), West Corporation (Nasdaq: WSTC) and Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN).

CybeRelease Decliners are Gander Mountain Company (Nasdaq: GMTN), Cardiome Pharma Corporation (Nasdaq: CRME), ADC Telecommunications, Inc. (Nasdaq: ADCT), Hoku Scientific, Inc. (Nasdaq: HOKU), INTAC International (Nasdaq: INTN), Ionatron, Inc. (Nasdaq: IOTN), Finlay Enterprises, Inc. (Nasdaq: FNLY) and Cubist Pharmaceuticals, Inc. (Nasdaq: CBST).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $995.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.